A nonwoven fabric for manufacturing an oral pouched product, where the nonwoven fabric is chewable to increase its liquid permeability. When the nonwoven fabric is used to form a pouch, it may thus control the release of substances from within the pouch. The nonwoven fabric can be formed by applying a diffusion restricting treatment to a base nonwoven fabric. The diffusion restricting treatment may include any of (a) incorporating a digestible compound; (b) incorporating a superabsorbent polymer; (c) incorporating a hydrophobic material; and (d) forming a deformable barrier layer.

A water-dissolvable nicotine tablet is disclosed, the nicotine tablet comprising at least a first compressed module and a second compressed module, wherein the first compressed module is an FDT-module and comprises nicotine, alkaline pH regulating agent, and disintegrant, and, wherein the second compressed module is a lozenge-module and comprises acidic pH regulating agent. Also, a method of manufacturing a nicotine tablet is disclosed.

There is described an aerosol provision article for use with an aerosol provision device for generating an inhalable medium including an aerosol. The aerosol provision article includes a first chamber for containing a first substance that is heatable to generate an aerosol; a conduit that extends through the first chamber, the conduit having an inlet through which aerosol generated from the first substance can enter the conduit and an outlet through which the aerosol can exit the conduit and a second chamber for receiving a second substance, wherein the second chamber is downstream of the outlet of the conduit. The article is arranged such that in use aerosol exiting the outlet of the conduit passes through the second substance received in the second chamber, and wherein the cross-sectional area of the conduit increases at or towards the outlet.

There is described an aerosol provision article for use with an aerosol provision device for generating an inhalable medium including an aerosol. The aerosol provision article includes a first chamber for containing a first substance that is heatable to generate an aerosol; a conduit that extends through the first chamber, the conduit having an inlet through which aerosol generated from the first substance can enter the conduit and an outlet through which the aerosol can exit the conduit and a second chamber for receiving a second substance, wherein the second chamber is downstream of the outlet of the conduit. The article is arranged such that in use aerosol exiting the outlet of the conduit passes through the second substance received in the second chamber, and wherein the cross-sectional area of the conduit increases at or towards the outlet.

A smokeless tobacco product configured for insertion into the mouth of a user of the product is provided, the smokeless tobacco product including a dissolvable or meltable base composition admixed with a tobacco material and a botanical material, wherein the botanical material is present in an amount of at least about 0.1% of the total dry weight of the smokeless tobacco product. The botanical material and the smokeless tobacco product can be characterized based on antioxidant content using the ORAC index or the FRAP index. An exemplary product has an ORAC index value of at least about 20 (μmol TE)/g or a FRAP index value of at least about 50 (μmol/Fe.sup.2+)/g.

A smokeless tobacco product configured for insertion into the mouth of a user of the product is provided, the smokeless tobacco product including a dissolvable or meltable base composition admixed with a tobacco material and a botanical material, wherein the botanical material is present in an amount of at least about 0.1% of the total dry weight of the smokeless tobacco product. The botanical material and the smokeless tobacco product can be characterized based on antioxidant content using the ORAC index or the FRAP index. An exemplary product has an ORAC index value of at least about 20 (μmol TE)/g or a FRAP index value of at least about 50 (μmol/Fe.sup.2+)/g.

The disclosure provides products configured for oral use, the products including one or more agents adapted to or configured to reduce irritation that may be associated with release of a component from the products. Xylitol in particular may be useful as an irritation reducing agent. The disclosure further provides methods of reducing irritation associated with the release of one or more components from an oral composition or product.

A smokeless tobacco product or medicinal nicotine product includes nicotine and camphor dissolved in a non-flavored oily carrier. Preferably, the camphor is present in a concentration ranging from about 600 ppm to about 1300 ppm. Also disclosed are methods of making such products.

A smokeless tobacco product or medicinal nicotine product includes nicotine and camphor dissolved in a non-flavored oily carrier. Preferably, the camphor is present in a concentration ranging from about 600 ppm to about 1300 ppm. Also disclosed are methods of making such products.

An oral tobacco pouch product includes a pouch wrapper formed of a web having a longitudinal integrated fin and lap seal. The pouch wrapper contains a filling material including tobacco material and optional additives. The longitudinal integrated fin and lap seal is formed on a forming collar.